Total Funding
79
52
Total FundingSeries B raised
Growth Score
-4 pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
36930
Vicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology.
- Koen Huygens: CQO
- Emmanuel Hanon: CEO
About the Company
Vicebio develops next-generation vaccines, focusing on respiratory disease prevention using its Molecular Clamp technology. The company aims to deliver broad protection and ready-to-use formulations. It has a pipeline of multipathogen respiratory vaccines to address global health challenges.
